Results 11 to 20 of about 14,159 (238)

Cadherin-16 (CDH16) immunohistochemistry: a useful diagnostic tool for renal cell carcinoma and papillary carcinomas of the thyroid

Scientific Reports, 2023
Cadherin-16 (CDH16) plays a role in the embryonal development in kidney and thyroid. Downregulation of CDH16 RNA was found in papillary carcinomas of the thyroid.
Maximilian Lennartz, Henrietta Csomós, Viktoria Chirico, Sören Weidemann, Natalia Gorbokon, Anne Menz, Franziska Büscheck, Claudia Hube-Magg, Doris Höflmayer, Christian Bernreuther, Niclas C. Blessin, Patrick Lebok, Guido Sauter, Stefan Steurer, Eike Burandt, David Dum, Till Krech, Ronald Simon, Sarah Minner, Frank Jacobsen, Till S. Clauditz, Andreas M. Luebke, Abdul Khalid Siraj, Fouad Al-Dayel, Khawla S. Al-Kuraya, Andrea Hinsch   +25 more
doaj   +1 more source

Genomic and Pathological Characterization of Multiple Renal Cell Carcinoma Regions in Patient With Tuberous Sclerosis Complex: A Case Report

Frontiers in Oncology, 2021
Tuberous sclerosis complex is a genetic disorder characterized by facial angiofibromas, intellectual disability, epilepsy, and tumor formation in multiple organs, including the kidney.
Tetsuya Yamamoto, Taigo Kato, Koji Hatano, Atsunari Kawashima, Takeshi Ujike, Shinichiro Fukuhara, Hiroshi Kiuchi, Ryoichi Imamura, Naokazu Ibuki, Kazuma Kiyotani, Masako Kurashige, Eichi Morii, Kazutoshi Fujita, Norio Nonomura, Motohide Uemura   +14 more
doaj   +1 more source

Double renal cell carcinoma with histological type of clear cell carcinoma and papillary carcinoma in the same kidney concurrently treated with robot‐assisted partial nephrectomy

IJU Case Reports, 2022
Introduction The presence of two different histologic types of renal cell carcinoma in the same kidney is rare in clinical practice. This report describes a patient with ipsilateral renal cell carcinomas, consisting of a clear cell renal cell carcinoma ...
Teruki Shimizu, Fumiya Hongo, Hikaru Takahashi, Atsuko Fujihara, Osamu Ukimura   +4 more
doaj   +1 more source

Oncological Outcomes of Primary Renal Malignancies other than Clear Cell Renal Carcinoma: A Retrospective Study from a Tertiary Centre in Southern India [PDF]

Journal of Clinical and Diagnostic Research, 2022
Introduction: A lot of research is available about clear cell Renal Carcinomas (ccRCC). But there are lesser known facts about other subtypes of renal malignancies.
Ramanitharan Manikandan, Ketan Mehra, Lalgudi Narayanan Dorairajan   +2 more
doaj   +1 more source

Gene expression profiling of clear cell papillary renal cell carcinoma: comparison with clear cell renal cell carcinoma and papillary renal cell carcinoma [PDF]

Modern Pathology, 2014
Clear cell papillary renal cell carcinoma is a distinct variant of renal cell carcinoma that shares some overlapping histological and immunohistochemical features of clear cell renal cell carcinoma and papillary renal cell carcinoma. Although the clear cell papillary renal cell carcinoma immunohistochemical profile is well described, clear cell ...
Andrew N. Young, R. Benjamin Isett, Kevin E. Fisher, Joseph Sirintrapun, William Harrison, Adeboye O. Osunkoya, Carlos S. Moreno, Qiqin Yin-Goen, Michael R. Rossi, Dianne Alexis   +9 more
openaire   +2 more sources

Case of hereditary papillary renal cell carcinoma [PDF]

Journal of Community Hospital Internal Medicine Perspectives, 2012
Renal cell carcinoma is the most common type of renal malignancy and it originates from the renal tubular epithelium. Due to the diversity in the histopathological and molecular characteristics, it is typically subclassified into five different categories.
Sheila F. Faraj, Sadaf Mustafa, Nima Jadidi, Ronald Rodriguez   +3 more
openaire   +4 more sources

The Utility of Mitochondrial Detection Methods Applied as an Additional Tool for the Differentiation of Renal Cell Tumors

Diagnostics, 2023
The precise differentiation of renal cell tumors (RCTs) is sometimes hard to achieve using standard imaging and histopathological methods, especially for those with eosinophilic features. It has been suggested that the vast overabundance of mitochondria,
Gorana Nikolic, Maja Zivotic, Sanja Cirovic, Sanja Despotovic, Dusko Dundjerovic, Sanja Radojevic Skodric   +5 more
doaj   +1 more source

Case of Hereditary Papillary Renal Cell Carcinoma Type I in a Patient With a Germline MET Mutation in Russia

Frontiers in Oncology, 2020
Hereditary papillary renal carcinoma (HPRC) is a rare autosomal dominant disease characterized by the development of multiple papillary type I renal cell carcinomas.
Dmitry S. Mikhaylenko, Dmitry S. Mikhaylenko, Dmitry S. Mikhaylenko, Alexey V. Klimov, Vsevolod B. Matveev, Svetlana I. Samoylova, Svetlana I. Samoylova, Vladimir V. Strelnikov, Dmitry V. Zaletaev, Dmitry V. Zaletaev, Ludmila N. Lubchenko, Boris Y. Alekseev, Marina V. Nemtsova, Marina V. Nemtsova   +13 more
doaj   +1 more source

MET variants with activating N-lobe mutations identified in hereditary papillary renal cell carcinomas still require ligand stimulation. [PDF]

Mol Oncol
MET variants in the N‐lobe of the kinase domain, found in hereditary papillary renal cell carcinoma, require ligand stimulation to promote cell transformation, in contrast to other RTK variants. This suggests that HGF expression in the microenvironment is important for tumor growth in such patients. Their sensitivity to MET inhibitors opens the way for
Guérin C, Vinchent A, Fernandes M, Damour I, Laratte A, Tellier R, Estevam GO, Meneboo JP, Villenet C, Descarpentries C, Fraser JS, Figeac M, Cortot AB, Rouleau E, Tulasne D.   +14 more
europepmc   +2 more sources

Mucinous tubular and spindle cell carcinoma: A difficult diagnosis

Urology Annals, 2021
Mucinous Tubular and Spindle Cell Carcinoma (MTSCC) is infrequently seen renal malignancy with favorable outcome, when diagnosed in the early stage. Once out of kidney it is have lethal course. Radiologically MTSCC is heterogeneously hypo-enhancing renal
Jyotsna Naresh Bharti, Gautam Ram Choudhary, Vijay Kumar Sarma Madduri, Taruna Yadav   +3 more
doaj   +1 more source